A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced an update on its ongoing ...

A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

tailored clinical outcomes, and statistical considerations to optimize trial efficiency. In this mouse study, an adenine base editor shows potential as a durable therapy for glycogen storage ...

The TikTok trend involves pushing yourself to make silly requests or ask a question that will likely get rejected.

The emerging combination therapy opportunities we are identifying for both LP-184 and LP-284 underscore the strength of our AI-guided approach. Seeing our drug candidates advance in clinical trials, ...

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

Pre-clinical data demonstrate robust anti-tumor activity and a novel off-the-shelf approach for GPC3+ solid tumors The abstract, titled "Pre-Clinical Efficacy of a Novel Anti-GPC3 In Vivo CAR-M for ...

The drug was added to their standard treatment and, after four weeks, significantly more patients with the EEG biomarker achieved clinical response ... top of background therapy, which is expected ...

It can include lifestyle changes, multimodal therapy, and environmental management ... If you’re living with dementia, participating in a clinical trial may offer you the opportunity to try ...

Unfortunately as clinic encounter conversations are not routinely recorded and are difficult to ethically share due to patient confidentiality, there are no sufficiently large clinic dialogue-note ...